Significance of capsular attachment and invasion of cancer tissues in prostate cancer. 2003

Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
Department of Urology, Asahi General Hospital, Chiba, Japan. webmaster@hospital.asahi.chiba.jp

BACKGROUND There is a discrepancy in tumor node metastasis (TNM) staging of capsular attachment and invasion; the condition was classified as pT3 in 1987, then as pT2 in 1992. Because capsular finding associated with radical prostatectomy is an important prognostic factor, the present study was conducted to characterize clinicopathological states of cancer tissues attached to and invading the capsule. METHODS Specimens removed by radical prostatectomy exhibiting pT2 or pT3 from 90 patients who did not receive any treatment before surgery were classified as Loc (24%, cancer tissues localized and apart from capsule), Inv (59%, attached to and invading but not penetrating capsule) and Pen (17%, penetrating capsule). Their clinicopathological profiles were examined. RESULTS Gleason score, volume of cancer tissues, seminal vesicle invasion, positive surgical margin and regional lymph node metastasis of Inv were distributed between those of Loc and Pen. Postoperative management was decided as routine check-up or endocrine therapy according to pathological findings. Median follow-up was 59 months. Prostate-specific antigen (PSA) relapse occurred in 13 patients, one of whom died of prostate cancer. The remaining of these patients lived. Rate of PSA relapse was not different between Loc and Inv, mainly due to endocrine therapy to Inv with high risk factors. CONCLUSIONS Pathological profile of Inv lies between those of Loc and Pen. Therefore, pT2a (1997) would be subclassified as Loc and Inv. Patients with Inv may be required to receive the respective management according to clinicopathological profile, which would be different to that of Loc.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
July 1995, The Prostate,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
April 1996, The Journal of urology,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
August 1998, Human pathology,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
March 1990, The American journal of surgical pathology,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
February 1974, Nihon Naibunpi Gakkai zasshi,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
March 2004, The Journal of urology,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
April 2012, The Prostate,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
March 2009, BJU international,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
December 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
Masashi Tanaka, and Noriyuki Suzuki, and Hiroomi Nakatsu, and Shino Murakami, and Osamu Matsuzaki, and Jun Shimazaki
May 2008, Zhonghua nan ke xue = National journal of andrology,
Copied contents to your clipboard!